Real-Life Use of Tocilizumab in the Treatment of Severe COVID-19 Pneumonia

Real-Life Use of Tocilizumab in the Treatment of Severe COVID-19 Pneumonia

Introduction. Coronavirus disease 2019 (COVID-19) can progress to severe respiratory compromise and lead to mortality due to induction of cytokine storm. Tocilizumab (TCZ) is approved by the FDA for the treatment of cytokine release syndrome (CRS). This study aims to analyze the outcomes among patie...

Full description

Saved in:
Bibliographic Details
Main Authors: Ruth Alex, Shabaz Mohiuddin Gulam, Kiran Kumar
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Advances in Virology
Online Access:http://dx.doi.org/10.1155/2022/7060466
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items